Dexcom (DXCM) Acquisitions (2021 - 2022)
Dexcom's (DXCM) quarterly Acquisitions came in at $700000.0 in Q3 2022, down 97.78% year-on-year from $31.6 million in Q3 2021, and down 78.12% on a QoQ basis from $3.2 million in Q1 2022.
Dexcom (DXCM) Acquisitions (2021 - 2022) Analysis & Trends
Dexcom (DXCM) has 2 years of Acquisitions data on file, last reported at $700000.0 in Q3 2022.
- On a quarterly basis, Acquisitions fell 97.78% year-over-year to $700000.0 in Q3 2022; TTM through Jun 2023 was $700000.0, a 97.9% decrease from a year earlier, with the FY2022 full-year figure at $3.9 million, down 87.09% from the prior year.
- Acquisitions for Q3 2022 stood at $700000.0, down from $3.2 million in the prior quarter.
- Over the last five years, Acquisitions for DXCM reached as high as $31.6 million in Q3 2021 and fell as low as -$1.4 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -268.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 3.20 Mn |
| Dec 31, 2021 | -1.40 Mn |
| Sep 30, 2021 | 31.60 Mn |